| 4URA: reference: Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor., England KS, Tumber A, Krojer T, Scozzafava G, Ng SS, Daniel M, Szykowska A, Che K, von Delft F, Burgess-Brown NA, Kawamura A, Schofield CJ, Brennan PE, Medchemcomm. 2014 Dec 1;5(12):1879-1886. PMID: 26682034 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).